Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1968;39(5):731–769.

Essai comparatif de deux types de traitement oral de la tuberculose pulmonaire (éthionamide+isoniazide, thioacétazone+isoniazide)

Comparative study of 2 types of oral therapy of pulmonary tuberculosis (ethionamide and isoniazid, thiacetazone and isoniazid)

F J Chicou, G Hétrick, M Huet, H Radenac, N Rist
PMCID: PMC2554438  PMID: 4183287

Full text

PDF
731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTMANN K. [Cross resistance between alpha-ethylthioiso-nicotinamide (Th 1314) and thiosemicarbazone (conteben)]. Tuberkulosearzt. 1960 Aug;14:525–529. [PubMed] [Google Scholar]
  2. BROUET G., MARCHE J., MODAI J. EVOLUTION DE LA NICOTINAMID'EMIE CHEZ LES TUBERCULEUX TRAIT'ES PAR CHIMIOTH'ERAPIE. Rev Tuberc Pneumol (Paris) 1963 Sep-Oct;27:871–880. [PubMed] [Google Scholar]
  3. CANETTI G., RIST N., GROSSET J. [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation]. Rev Tuberc Pneumol (Paris) 1963 Feb-Mar;27:217–272. [PubMed] [Google Scholar]
  4. CHAMBATTE C., PERNOD J., BATIME J., KERMAREC J., BASCANDS J., ZENNOU B. LE TRAITEMENT D'ATTAQUE DES FORMES R'ECENTES DE LA TUBERCULOSE PULMONAIRE COMMUNE PAR L'ASSOCIATION 'A L'ISONIAZIDE DE DOSES QUOTIDIENNES DE 500 MILLIGRAMMES D'ETHIONAMIDE. G Ital Chemioter. 1963 Apr-Jun;10:118–125. [PubMed] [Google Scholar]
  5. CHICOU J., HETRICK G., LAHLOU M., LE HIR M., MERCIEP A., NEEL R., RIST N., VINCENT J. [Controlled investigation of 3 types of oral treatment of pulmonary tuberculosis made in Morocco, at Tangiers (I.N.H. with ethioniamide; I.N.H. with PAS; I.N.H. alone). (Early results after 1 year of observation)]. Rev Tuberc Pneumol (Paris) 1961 Sep-Oct;25:1031–1056. [PubMed] [Google Scholar]
  6. CHICOU J., HETRICK G., LE HIR M., MERCIER A., MUNOZ J., IRUNBERRY J., NEEL R., RIST N., VINCENT J. [Trial chemotherapy of 103 cases of pulmonary tuberculosis, all resistant to 1 or several antibiotics, in a country with high tuberculosis endemia (early results after at least 4 months' treatment. Reflections and practical suggestions on so-called "chronic" tuberculosis)]. Rev Tuberc Pneumol (Paris) 1962 Jul-Aug;26:867–883. [PubMed] [Google Scholar]
  7. FOX W. REALISTIC CHEMOTHERAPEUTIC POLICIES FOR TUBERCULOSIS IN THE DEVELOPING COUNTRIES. Br Med J. 1964 Jan 18;1(5376):135–142. doi: 10.1136/bmj.1.5376.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRUMBACH F. [The treatment of experimental tuberculosis in mice by the association of isoniazid and ethionamide in different doses. Application of the results to clinical posology]. Rev Tuberc Pneumol (Paris) 1961 Dec;25:1365–1385. [PubMed] [Google Scholar]
  9. JOSEPH S., MITCHISON D. A., RAMACHANDRAN K., SELKON J. B., SUBBAIAH T. V. VIRULENCE IN THE GUINEA-PIG AND SENSITIVITY TO PAS AND THIACETAZONE OF TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS WITH PULMONARY TUBERCULOSIS. Tubercle. 1964 Dec;45:354–359. doi: 10.1016/s0041-3879(64)80049-0. [DOI] [PubMed] [Google Scholar]
  10. LEHIR M., CHICOU J., HETRICK G., MERCIER A., NEEL R., RIST N. ESSAI CLINIQUE CONTR OL'E DE TROIS TYPES DE TRAITEMENT ORAL DE LA TUBERCULOSE PULMONAIRE. (ISONIAZIDE + ETHIONAMIDE, ISONIAZIDE + PAS, ISONIAZIDE SEUL) Bull World Health Organ. 1964;30:701–732. [PMC free article] [PubMed] [Google Scholar]
  11. Lees A. W. Ethionamide, 500 mg. daily, plus isoniazid, 500 mg. or 300 mg. daily in previously untreated patients with pulmonary tuberculosis. Am Rev Respir Dis. 1967 Jan;95(1):109–111. doi: 10.1164/arrd.1967.95.1.109. [DOI] [PubMed] [Google Scholar]
  12. MITCHISON D. A., LLOYD J. COMPARISON OF THE SENSITIVITY TO THIACETAZONE OF TUBERCLE BACILLI FROM PATIENTS IN BRITAIN, EAST AFRICA, SOUTH INDIA AND HONG KONG. Tubercle. 1964 Dec;45:360–369. doi: 10.1016/s0041-3879(64)80050-7. [DOI] [PubMed] [Google Scholar]
  13. MITCHISON D. A. THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES. Bull Int Union Tuberc. 1964 Sep;35:287–306. [PubMed] [Google Scholar]
  14. RIST N., CALS S., JULLIEN W. Aspects variés de la sensibilité du bacille tuberculeux a la para-acétylbenzaldéhyde-thiosemicarbazone (TbI) en milieu de Youmans. Ann Inst Pasteur (Paris) 1951 Sep;81(3):324–328. [PubMed] [Google Scholar]
  15. THOMAS K. L., JOSEPH S., SUBBAIAH T., SELKON J. B. Identification of tubercle bacilli from Indian patients with pulmonary tuberculosis. Bull World Health Organ. 1961;25:747–758. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES